AtriCure (NASDAQ:ATRC) Receives “Market Outperform” Rating from JMP Securities
AtriCure (NASDAQ:ATRC – Get Free Report)‘s stock had its “market outperform” rating reissued by analysts at JMP Securities in a report issued on Monday,Benzinga reports. They presently have a $60.00 price objective on the medical device company’s stock. JMP Securities’ price target would suggest a potential upside of 44.54% from the stock’s current price. A […]
AtriCure (NASDAQ:ATRC – Get Free Report)‘s stock had its “market outperform” rating reissued by analysts at JMP Securities in a report issued on Monday,Benzinga reports. They presently have a $60.00 price objective on the medical device company’s stock. JMP Securities’ price target would suggest a potential upside of 44.54% from the stock’s current price. A […]
